Antitumor anthracyclines: Recent developments (Q40178434)

18 September 2017

1 reference

title

Antitumor anthracyclines: recent developments (English)

1 reference

18 September 2017

Antitumor anthracyclines: Recent developments (English)

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

11 October 2023

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

11 October 2023

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

11 October 2023

author name string

F. Arcamone

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6374338

11 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6374338

11 October 2023

publication date

1 April 1984

1 reference

full work available at URL

18 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmed.2610040203

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

https://onlinelibrary.wiley.com/doi/full/10.1002/med.2610040203

11 October 2023

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Medicinal Research Reviews

11 October 2023

published in

1 reference

18 September 2017

4

1 reference

18 September 2017

2

1 reference

18 September 2017

153-188

1 reference

Interaction of adriamycin in vitro with cardiac myofibrillar proteins

18 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040203

Chemical interactions of cardiolipin with daunorubicin and other intercalating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040203

Differential cytotoxicity of daunomycin in tumour cells is related to glutathione-dependent hydrogen peroxide metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040203

New anthracycline glycosides: 4-O-demethyl-11-deoxydoxorubicin and analogues from Streptomyces peucetius var. aureus

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

The anthracycline antineoplastic drugs

11 October 2023

7

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Nucleic acid binding drugs. Some conformational properties of the anti-cancer drug daunomycin and several of its derivatives:

11 October 2023

16

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

An extended conformational analysis of doxorubicin

11 October 2023

17

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

A conformational analysis of daunomycin considering D-ring repucker

11 October 2023

18

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Anthracycline antitumor antibiotic nucleic-acid interactions. Structural aspects of the daunomycin poly(dA-dT) complex in solution

11 October 2023

19

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Helix-coil transition of the dG-dC-dG-dC self-complementary duplex and complex formation with daunomycin in solution

11 October 2023

20

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Hydrogen bonding, overlap geometry, and sequence specificity in anthracycline antitumor antibiotic.DNA complexes in solution

11 October 2023

21

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Proton nuclear magnetic resonance study of the self-complementary hexanucleotide d(pTpA)3 and its interaction with daunomycin

11 October 2023

22

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

An NMR study of the interaction of daunomycin with dinucleotides and dinucleoside phosphates

11 October 2023

23

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Interaction of actinomycin D, ethidium, quinacrine, daunorubicin, and tetralysine with DNA: 31P NMR chemical shift and relaxation investigation

11 October 2023

24

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Interaction of adriamycin with DNA as studied by resonance Raman spectroscopy.

11 October 2023

25

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Molecular structure of an anticancer drug-DNA complex: daunomycin plus d(CpGpTpApCpG).

11 October 2023

29

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

11 October 2023

Molecular Pharmacology

30

16

357

Grant

1979

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

11 October 2023

Molecular Pharmacology

31

17

100

Mong

1980

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Studies on interaction of anthracycline antibiotics and deoxyribonucleic acid: equilibrium binding studies on interaction of daunomycin with deoxyribonucleic acid

11 October 2023

33

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Effect of divalent cations on the daunomycin-deoxyribonucleic acid complex

11 October 2023

35

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

The effect of physiological levels of divalent metal ions on the interaction of daunomycin with DNA: evidence of a ternary daunomycin-Cu2+-DNA complex

11 October 2023

36

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Interaction of copper(II) ions with the daunomycin-calf thymus deoxyribonucleic acid complex

11 October 2023

37

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Inhibition of DNA Synthesis in Mammalian Cells by Daunomycin. Preferential Inhibition of Replicon Initiation at Low Concentrations

11 October 2023

38

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Two types of adriamycin inhibition of a homologous RNA synthesizing system from L1210 cells

11 October 2023

39

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

11 October 2023

40

39

3661

Kanter

1979

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

The interaction of daunorubicin and doxorubicin with DNA and chromatin

11 October 2023

41

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

The interaction of adriamycin with nuclear DNA: evidence for a drug induced compaction of isolated chromatin

11 October 2023

42

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Adriamycin-induced compaction of isolated chromatin

11 October 2023

43

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Effects of adriamycin on heart and skeletal muscle chromatin

11 October 2023

44

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Heart mitochondrial DNA synthesis: Preferential inhibition by adriamycin

11 October 2023

45

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Deoxyribonucleic acid binding studies on several new anthracycline antitumor antibiotics. Sequence preference and structure-activity relationships of marcellomycin and its analogs as compared to adriamycin

11 October 2023

47

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Structure-activity relationships of anthracyclines relative to cytotoxicity and effects on macromolecular synthesis in L1210 leukemia cells

11 October 2023

48

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Viscometric and fluorometric studies of deoxyribonucleic acid interactions of several new anthracyclines

11 October 2023

49

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

11 October 2023

Molecular Pharmacology

50

21

196

Du Vernay

1981

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Binding mode of chemically activated semiquinone free radicals from quinone anticancer agents to DNA

11 October 2023

51

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Evidence of soluble proteins binding adriamycin by affinity chromatography

11 October 2023

52

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Inhibition of cardiac NADP-linked isocitrate dehydrogenase by adriamycin

11 October 2023

53

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Adriamycin affects plasma membrane redox functions

11 October 2023

54

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Complexation of anthracycline antibiotics by the apo egg white riboflavin binding protein

11 October 2023

56

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

The interaction of adriamycin with small unilamellar vesicle liposomes. A fluorescence study

11 October 2023

58

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Evidence of a specific complex between adriamycin and negatively-charged phospholipids.

11 October 2023

59

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Evidence of a complex between adriamycin derivatives and cardiolipin: possible role in cardiotoxicity

11 October 2023

60

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Adriamycin inhibits the formation of non-bilayer lipid structures in cardiolipin-containing model membranes

11 October 2023

61

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Adriamycin inactivates cytochrome c oxidase by exclusion of the enzyme from its cardiolipin essential environment

11 October 2023

62

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Physiological chemistry and physics

11 October 2023

63

11

405

Pietronigro

1979

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

A proposed reaction mechanism for the enzymatic reductive cleavage of glycosidic bond in anthracycline antibiotics

11 October 2023

65

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

The molecular basis for complexation of adriamycin with flavin mononucleotide and flavin adenine dinucleotide

11 October 2023

67

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Spin-trapping and direct electron spin resonance investigations of the redox metabolism of quinone anticancer drugs

11 October 2023

68

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Generation of hydroxyl radical by anticancer quinone drugs, carbazilquinone, mitomycin C, aclacinomycin A and adriamycin, in the presence of NADPH-cytochrome P-450 reductase

11 October 2023

70

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Stimulation by adriamycin of rat heart and liver microsomal NADPH-dependent lipid peroxidation

11 October 2023

73

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

In vivo effects of several anthracyclines on DNA integrity.

11 October 2023

77

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Decomposition of unsaturated phospholipid by iron-ADP-adriamycin co-ordination complex

11 October 2023

78

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin-iron complex

11 October 2023

79

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Adriamycin stimulates only the iron ion-induced, NADPH-dependent microsomal alkane formation

11 October 2023

80

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Further studies on adriamycin induced in vitro lipid peroxidation

11 October 2023

82

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Journal of Pharmaceutical Sciences

11 October 2023

85

author name string

Menozzi

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

A comparison of the lethal and kinetic effects of doxorubicin and 4'-epi-doxorubicin in vitro.

11 October 2023

88

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Evaluation of new anthracycline analogs with the human tumor stem cell assay

11 October 2023

89

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

DNA damage by anthracycline drugs in human leukemia cells

11 October 2023

90

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Antileukemic activity of 4-demethoxydaunorubicin in mice

11 October 2023

113

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Fluorescence assay of tissue distribution of 4-demethoxydaunorubicin and 4-demethoxydoxorubicin in mice bearing solid tumors

11 October 2023

114

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

11 October 2023

123

40

4682

Giuliani

1980

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Chemotherapy of human colorectal tumor xenografts in athymic mice with clinically active drugs: 5-fluorouracil and 1-3-bis-(-2-chloroethyl)-1-nitrosourea (BCNU). Comparison with doxorubicin derivatives: 4'deoxydoxorubicin and 4'-O-methyldoxorubicin

11 October 2023

124

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Inhibition of Cellular DNA Synthesis and Lack of Antileukemic Activity by Non-Photoactivated Hematoporphyrin Derivative

11 October 2023

125

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Fluorescence assays and pharmacokinetic studies of 4′-deoxydoxorubicin and doxorubicin in organs of mice bearing solid tumors

11 October 2023

128

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Enhanced antitumor properties of 3'-(4-morpholinyl) and 3'-(4-methoxy-1-piperidinyl) derivatives of 3'-deaminodaunorubicin

11 October 2023

133

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

3'-deamino-3'-morpholino derivatives of daunomycin, adriamycin and carminomycin

11 October 2023

134

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

11 October 2023

Cancer Treatment Reports

135

65

277

Sela

1981

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Amino acid and dipeptide derivatives of daunorubicin. 1. Synthesis, physicochemical properties, and lysosomal digestion

11 October 2023

136

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

11 October 2023

137

40

3530

Jaenke

1980

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Cancer Chemotherapy and Pharmacology

11 October 2023

138

8

193

Deprez-deCampenere

1982

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Tetrahydropyranyl derivatives of daunomycin and adriamycin

11 October 2023

139

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

11 October 2023

140

42

1462

Tsuruo

1982

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

7-O-(3-Amino-2,3,6-trideoxy-α-D-ribo-hexopyranosyl)daunomycinone, a configurational analog of daunorubicin

11 October 2023

141

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Cross resistance and cellular uptake of 4′-O-methyldoxorubicin in experimental tumors with acquired resistance to doxorubicin

11 October 2023

143

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Synthesis, biological and biochemical properties of new anthracyclines modified in the aminosugar moiety

11 October 2023

144

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Adriamycin analogues. Preparation and antitumor evaluation of 7-O-(beta-D-glucosaminyl)daunomycinone and 7-O-(beta-D-glucosaminyl)adriamycinone and their N-trifluoroacetyl derivatives

11 October 2023

146

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Synthesis and antitumor activity of 7-O-(3,4-di-O-acetyl-2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)adriamycinone

11 October 2023

147

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

New adriamycin analogs. Synthesis and antitumor activity of 14-substituted 7-O-(3,4-di-O-acetyl-2,6-dideoxy-.ALPHA.-l-lyxo-hexopyranosyl)daunomycinones

11 October 2023

148

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Adriamycin analogues. Novel anomeric ribofuranoside analogues of daunorubicin

11 October 2023

151

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Chemical modification of anthracycline antibiotics IV. Synthesis of new anthracyclines with trisaccharide

11 October 2023

153

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Further studies on the generation of reactive oxygen species from activated anthracyclines and the relationship to cytotoxic action and cardiotoxic effects

11 October 2023

159

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

11 October 2023

160

42

117

Glazer

1982

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

11 October 2023

161

42

2687

Zwelling

1982

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

11 October 2023

163

40

387

DuVernay

1980

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

New anthracycline glycosides from Micromonospora. II. Isolation, characterization and biological properties.

11 October 2023

164

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Structures of novel anthracycline antitumor antibiotics from Micromonospora peucetica

11 October 2023

165

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

Synthesis of 4-demethoxy-11-deoxy-analogs of daunomycin and adriamycin

11 October 2023

166

1 reference

https://api.crossref.org/works/10.1002/MED.2610040203

11 October 2023

Identifiers

1 reference

18 September 2017

1 reference